In vitro antidiabetic activity of Treculia africana leaf extracts: identification of chlorogenic acid and α-mangostin
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Victorine Lorette Yimgang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial & Biocontrol Agents Unit (AmBcAU), Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, Universit…. Hauptthemen laut MEDLINE: Chlorogenic Acid, Plant Extracts, Xanthones, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Ministry of University and Research.
Abstract (Originalsprache)
Objective
This research studied two extracts from Treculia africana leaves for their potential against hyperglycaemia-related disorders.
Methods
The influence of the extracts on α-glucosidase activity and albumin glycation was investigated, and cell viability was estimated in HT-29 human colorectal cells. Phenolic and flavonoid contents and antiradical activity were also detected. The extracts were examined using HPLC-DAD analysis. Key findings The methanol and dichloromethane leaf extracts showed a significant concentration-dependent inhibition of α-glucosidase activity (IC50= 3.73 and 21.28 µg/ml, respectively). Both extracts also inhibited ribose-induced glycation of bovine serum albumin from 250 µg/ml. Phytochemical analysis revealed the presence of chlorogenic acid and α-mangostin in the extracts. The extracts did not change HT-29 cell viability up to 250 µg/ml, thus showing very low cytotoxicity.
Conclusions
The methanol leaf extract of T. africana inhibited α-glucosidase activity in a concentration-dependent manner, supporting the use of the leaves in traditional medicine to control hyperglycaemia. Chlorogenic acid and α-mangostin, the latter identified for the first time in this species, were found in the T. africana leaves. Further, in vivo studies and pilot clinical trials should be conducted using standardized T. africana leaf extracts to evaluate their potential effectiveness in diabetes mellitus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Antimicrobial & Biocontrol Agents Unit (AmBcAU), Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
ORCID-Profile: Guglielmina Froldi
Förderung
- Ministry of University and Research
Zitieren
APA
Yimgang, V. L., Pangrazzi, E., Djeujo, F. M., Melogmo, Y. K. D., Tchinda Taghu, F. L., Kouipou, R. M. T., Boyom, F. F., & Froldi, G. (2025). In vitro antidiabetic activity of Treculia africana leaf extracts: identification of chlorogenic acid and α-mangostin. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf003
Vancouver
Yimgang VL, Pangrazzi E, Djeujo FM, Melogmo YKD, Tchinda Taghu FL, Kouipou RMT, et al. In vitro antidiabetic activity of Treculia africana leaf extracts: identification of chlorogenic acid and α-mangostin. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf003
BibTeX
@article{Yimgang2025,
author = {Yimgang, Victorine Lorette and Pangrazzi, Elisa and Djeujo, Francine Medjiofack and Melogmo, Yanick Kevin Dongmo and Tchinda Taghu, Franklin Loïc and Kouipou, Rufin Marie Toghueo and Boyom, Fabrice Fekam and Froldi, Guglielmina},
title = {In vitro antidiabetic activity of Treculia africana leaf extracts: identification of chlorogenic acid and α-mangostin},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf003}
}
EUVIMED